GILD:NSD-Gilead Sciences Inc (USD)

COMMON STOCK | Drug Manufacturers - General |

Last Closing

USD 110.03

Change

+2.38 (+2.21)%

Market Cap

USD 121.14B

Volume

7.68M

Analyst Target

USD 77.75
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; Marengo Therapeutics; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-20 )

Largest Industry Peers for Drug Manufacturers - General

Symbol Name Price(Change) Market Cap
AZN AstraZeneca PLC ADR

+0.75 (+1.02%)

USD 228.18B
AMGN Amgen Inc

+3.66 (+1.24%)

USD 148.05B
SNY Sanofi ADR

+0.53 (+0.99%)

USD 135.22B
BIIB Biogen Inc

+0.40 (+0.29%)

USD 20.97B
GRFS Grifols SA ADR

+0.15 (+2.03%)

USD 7.13B
AMRN Amarin Corporation PLC

N/A

USD 0.25B
MIRA MIRA Pharmaceuticals, Inc. Com..

-0.05 (-4.31%)

USD 0.02B
SCLX Scilex Holding Company

-0.02 (-4.36%)

N/A
SCLXW Scilex Holding Company

-0.01 (-8.36%)

N/A

ETFs Containing GILD

BTEC:SW iShares Nasdaq US Biotech.. 8.25 % 0.00 %

+0.05 (+-0.20%)

N/A
UBIO 7.77 % 0.95 %

N/A

N/A
FTXH First Trust Nasdaq Pharma.. 5.18 % 0.60 %

+0.20 (+-0.20%)

USD 0.02B
TBG EA Series Trust 4.28 % 0.00 %

+0.04 (+-0.20%)

USD 0.11B
KNGU:CA Brompton U.S. Cash Flow K.. 4.23 % 0.00 %

N/A

CAD 0.01B
QQQG Pacer Nasdaq 100 Top 50 C.. 4.05 % 0.00 %

-0.18 (-0.20%)

USD 2.69M
UDI USCF ETF Trust 4.00 % 0.00 %

-0.17 (-0.20%)

N/A
JPHG:PA Amundi Index Solutions - .. 3.90 % 0.00 %

-3.33 (-0.20%)

N/A
JPHC:SW Amundi Index Solutions - .. 3.90 % 0.00 %

-1.72 (-0.20%)

USD 5.59M
JPHE:SW Amundi Index Solutions - .. 3.90 % 0.00 %

N/A

USD 0.06B
JPHG:SW Amundi Index Solutions - .. 3.90 % 0.00 %

N/A

USD 3.94M
JPHU:SW Amundi Index Solutions - .. 3.90 % 0.00 %

N/A

USD 0.05B
JPNK:SW Amundi Index Solutions - .. 3.90 % 0.00 %

N/A

USD 0.07B
JPNY:SW Amundi Index Solutions - .. 3.90 % 0.00 %

N/A

USD 5.99B
BAMD Brookstone Dividend Stock.. 3.49 % 0.00 %

+0.12 (+-0.20%)

USD 0.09B
CBUF:F 3.37 % 0.00 %

N/A

N/A
MDLV EA Series Trust - Morgan .. 3.19 % 0.00 %

+0.10 (+-0.20%)

N/A
WHCS:SW iShares MSCI World Health.. 3.19 % 0.00 %

N/A

N/A
QNXT iShares Nasdaq-100 ex Top.. 3.18 % 0.00 %

-0.16 (-0.20%)

USD 0.01B
MVFD Northern Lights Fund Trus.. 2.87 % 0.00 %

-0.11 (-0.20%)

USD 0.07B
MHOT:AU VanEck Morningstar Wide M.. 2.86 % 0.00 %

+0.49 (+-0.20%)

N/A
MOTV:LSE VanEck Morningstar US Wid.. 2.76 % 0.00 %

-0.01 (-0.20%)

USD 0.06B
MOTU:LSE VanEck Morningstar US Wid.. 2.76 % 0.00 %

+0.11 (+-0.20%)

USD 0.06B
MOAT:AU VanEck Morningstar Wide M.. 2.74 % 0.00 %

-0.06 (-0.20%)

USD 1.09B
WMOT:XETRA 2.51 % 0.00 %

N/A

N/A
CURE:AU ETFS S&P Biotech ETF 2.42 % 0.00 %

+0.60 (+-0.20%)

USD 0.04B
ZYUS:AU ANZ S&P 500 High Yield Lo.. 2.35 % 0.00 %

+0.06 (+-0.20%)

USD 0.08B
HEAL:SW iShares Healthcare Innova.. 2.21 % 0.00 %

+0.01 (+-0.20%)

N/A
QUVU Hartford Quality Value ET.. 2.21 % 0.00 %

N/A

USD 0.18B
SAGP The Advisorsa Inner Circl.. 2.09 % 0.00 %

-0.04 (-0.20%)

USD 0.04B
DHS:SW 2.04 % 0.00 %

N/A

N/A
DHSA:SW WisdomTree US Equity Inco.. 2.04 % 0.00 %

N/A

N/A
FLCV Federated Hermes ETF Trus.. 1.98 % 0.00 %

-0.08 (-0.20%)

USD 0.02B
LABU Direxion Daily S&P Biotec.. 1.83 % 1.14 %

+0.55 (+-0.20%)

USD 0.77B
ZUH:CA BMO Equal Weight US Healt.. 1.76 % 0.39 %

+0.33 (+-0.20%)

CAD 0.22B
INCM:AU BetaShares Global Income .. 1.75 % 0.00 %

+0.03 (+-0.20%)

USD 0.03B
MVEC:SW iShares Edge MSCI World M.. 1.44 % 0.00 %

N/A

USD 0.17B
MVEW:SW iShares Edge MSCI World M.. 1.44 % 0.00 %

N/A

USD 0.43B
MVWE:SW iShares Edge MSCI World M.. 1.44 % 0.00 %

N/A

USD 0.07B
MVEW:LSE iShares Edge MSCI World M.. 1.42 % 0.00 %

-0.01 (-0.20%)

USD 0.43B
EVO:CA Evovest Global Equity ETF 0.96 % 0.00 %

-0.10 (-0.20%)

N/A
DGVA:AU Dimensional Global Value .. 0.94 % 0.00 %

-0.05 (-0.20%)

N/A
PAPI Morgan Stanley ETF Trust 0.64 % 0.00 %

+0.08 (+-0.20%)

USD 0.14B
WELE:XETRA 0.59 % 0.00 %

N/A

N/A
JPGL:SW JPM Global Equity Multi-F.. 0.32 % 0.00 %

N/A

N/A
BBH VanEck Biotech ETF 0.00 % 0.35 %

+1.08 (+-0.20%)

USD 0.40B
BIB ProShares Ultra Nasdaq Bi.. 0.00 % 0.95 %

+0.65 (+-0.20%)

USD 0.06B
BIS ProShares UltraShort Nasd.. 0.00 % 0.95 %

-0.18 (-0.20%)

USD 3.30M
BSCK 0.00 % 0.10 %

N/A

N/A
BSCL 0.00 % 0.10 %

N/A

N/A
BSCQ Invesco BulletShares 2026.. 0.00 % 0.10 %

+0.01 (+-0.20%)

N/A
CBND 0.00 % 0.16 %

N/A

N/A
CYH:CA iShares Global Monthly Di.. 0.00 % 0.66 %

-0.07 (-0.20%)

CAD 0.14B
DVP Roundhill Acquirers Deep .. 0.00 % 0.48 %

N/A

N/A
ESGW 0.00 % 0.40 %

N/A

N/A
FCY 0.00 % 0.84 %

N/A

N/A
FCY:CA 0.00 % 0.95 %

N/A

N/A
FDL First Trust Morningstar D.. 0.00 % 0.45 %

+0.19 (+-0.20%)

N/A
FLAG 0.00 % 1.52 %

N/A

N/A
IBB iShares Biotechnology ETF 0.00 % 0.47 %

+0.69 (+-0.20%)

USD 6.39B
IBCD 0.00 % 0.10 %

N/A

N/A
MOAT VanEck Morningstar Wide M.. 0.00 % 0.49 %

+0.15 (+-0.20%)

N/A
ONEV SPDR® Russell 1000 Low V.. 0.00 % 0.20 %

-0.19 (-0.20%)

N/A
ONEY SPDR® Russell 1000® Yie.. 0.00 % 0.20 %

+0.11 (+-0.20%)

N/A
PBE Invesco Dynamic Biotechno.. 0.00 % 0.57 %

-0.01 (-0.20%)

N/A
IVFVC 0.00 % 0.00 %

N/A

N/A
VSL 0.00 % 0.65 %

N/A

N/A
FHI:CA CI Health Care Giants Cov.. 0.00 % 0.75 %

+0.07 (+-0.20%)

CAD 0.10B
JIGB 0.00 % 0.14 %

N/A

N/A
ZHU:CA BMO Equal Weight US Healt.. 0.00 % 0.00 %

+0.01 (+-0.20%)

CAD 0.01B
FHI-B:CA CI Health Care Giants Cov.. 0.00 % 0.00 %

N/A

CAD 0.05B
SPBO SPDR Portfolio Corporate .. 0.00 % 0.00 %

+0.05 (+-0.20%)

USD 1.86B
BTEC:LSE iShares Nasdaq US Biotech.. 0.00 % 0.00 %

+0.04 (+-0.20%)

N/A
BTEK:LSE iShares Nasdaq US Biotech.. 0.00 % 0.00 %

N/A

N/A
BTEE:LSE iShares Nasdaq US Biotech.. 0.00 % 0.00 %

+0.04 (+-0.20%)

N/A
RJZ 0.00 % 0.75 %

N/A

N/A
SCIU 0.00 % 0.19 %

N/A

N/A
SICK 0.00 % 0.95 %

N/A

N/A
XBI SPDR® S&P Biotech ETF 0.00 % 0.35 %

+0.19 (+-0.20%)

N/A
XMS:CA iShares Edge MSCI Min Vol.. 0.00 % 0.33 %

-0.11 (-0.20%)

N/A
ZBIO Zenas BioPharma, Inc. Com.. 0.00 % 0.95 %

+1.38 (+-0.20%)

N/A
FCW:CA 0.00 % 0.90 %

N/A

N/A
SPDV AAM S&P 500 High Dividend.. 0.00 % 0.29 %

+0.16 (+-0.20%)

USD 0.07B
DHS:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

-6.80 (-0.20%)

N/A
DHSA:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

+0.02 (+-0.20%)

N/A
DHSD:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

+0.03 (+-0.20%)

N/A
DHSG:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

+3.25 (+-0.20%)

N/A
DHSP:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

-8.50 (-0.20%)

N/A
DRDR:LSE iShares Healthcare Innova.. 0.00 % 0.00 %

-1.00 (-0.20%)

N/A
HEAL:LSE iShares Healthcare Innova.. 0.00 % 0.00 %

+0.04 (+-0.20%)

N/A
MINV:LSE iShares VI Public Limited.. 0.00 % 0.00 %

-14.00 (-0.20%)

N/A
MVOL:LSE iShares Edge MSCI World M.. 0.00 % 0.00 %

+0.08 (+-0.20%)

N/A
XFVT:LSE Xtrackers FTSE Vietnam Sw.. 0.00 % 0.00 %

+2.75 (+-0.20%)

N/A
JPHC:PA Amundi Index Solutions - .. 0.00 % 0.00 %

-1.46 (-0.20%)

USD 4.54M
UBBB:PA Amundi Index Solutions - .. 0.00 % 0.00 %

+0.19 (+-0.20%)

USD 0.13B
2B70:F 0.00 % 0.00 %

N/A

N/A
JP40:F 0.00 % 0.00 %

N/A

N/A
JP4H:F 0.00 % 0.00 %

N/A

N/A
WTD9:F 0.00 % 0.00 %

N/A

N/A
WTDY:F 0.00 % 0.00 %

N/A

N/A
WTEU:F 0.00 % 0.00 %

N/A

N/A
2B70:XETRA 0.00 % 0.00 %

N/A

N/A
2B78:XETRA 0.00 % 0.00 %

N/A

N/A
JP40:XETRA 0.00 % 0.00 %

N/A

N/A
JP4H:XETRA 0.00 % 0.00 %

N/A

N/A
WTD9:XETRA 0.00 % 0.00 %

N/A

N/A
WTDY:XETRA 0.00 % 0.00 %

N/A

N/A
WTEU:XETRA 0.00 % 0.00 %

N/A

N/A
ZGEN:CA 0.00 % 0.00 %

N/A

N/A
ZINN:CA 0.00 % 0.00 %

N/A

N/A
HDLB ETRACS Monthly Pay 2xLeve.. 0.00 % 0.00 %

+0.23 (+-0.20%)

USD 8.32M
JPGL:XETRA 0.00 % 0.00 %

N/A

N/A
MVEW:XETRA 0.00 % 0.00 %

N/A

N/A
SCHJ Schwab 1-5 Year Corporate.. 0.00 % 0.00 %

N/A

N/A
FLSP Franklin Liberty Systemat.. 0.00 % 0.00 %

-0.02 (-0.20%)

USD 0.30B
HDIV 0.00 % 0.00 %

N/A

N/A
BMED BlackRock Future Health E.. 0.00 % 0.00 %

+0.10 (+-0.20%)

USD 3.22M
CBUF:XETRA 0.00 % 0.00 %

N/A

N/A
FBT:LSE First Trust Global Funds .. 0.00 % 0.00 %

-4.50 (-0.20%)

USD 8.65M
FBTU:LSE First Trust Global Funds .. 0.00 % 0.00 %

+0.09 (+-0.20%)

USD 8.62M
TDOC:CA TD Global Healthcare Lead.. 0.00 % 0.00 %

+0.02 (+-0.20%)

CAD 0.08B
IBBQ Invesco Nasdaq Biotechnol.. 0.00 % 0.00 %

+0.08 (+-0.20%)

USD 0.04B
2B78:F 0.00 % 0.00 %

N/A

N/A
JPGL:F 0.00 % 0.00 %

N/A

N/A
GDOC Goldman Sachs ETF Trust 0.00 % 0.00 %

+0.25 (+-0.20%)

USD 0.02B
CSY9:XETRA 0.00 % 0.00 %

N/A

N/A
WDMVO:SW UBS (Irl) ETF plc - Facto.. 0.00 % 0.00 %

N/A

USD 0.29B

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers - General) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 19.12% 90% A- 86% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 19.12% 90% A- 86% B+
Trailing 12 Months  
Capital Gain 51.18% 100% F 85% B
Dividend Return 4.23% 75% C 69% C-
Total Return 55.41% 100% F 86% B+
Trailing 5 Years  
Capital Gain 57.86% 100% F 76% C+
Dividend Return 20.89% 100% F 77% C+
Total Return 78.75% 100% F 80% B-
Average Annual (5 Year Horizon)  
Capital Gain 1.23% 78% C+ 42% F
Dividend Return 4.81% 78% C+ 49% F
Total Return 3.58% 75% C 74% C
Risk Return Profile  
Volatility (Standard Deviation) 25.13% 67% D+ 70% C-
Risk Adjusted Return 19.13% 78% C+ 52% F
Market Capitalization 121.14B 63% D 99% N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector